Here is an overview of some of the stories that we followed on science political blog of science Insider: as the availability of vaccine against swine flu is increasing steadily, the US Centers for Disease Control and Prevention (CDC) is intensifying its efforts against a growing sense of complacency in the country about the pandemic. At a press conference last week, Anne Schuchat, director of the CDC National Center for Immunization and Respiratory Diseases, said that 76 children in the US have died of the new H1N1 virus since it resurfaced in April . She compared this with the last three flu seasons in the country, which recorded between 46 and 88 deaths in this age group. "It is only the beginning of October," Schuchat said. "Of course, the flu season often will last all the way until May."
First impressions can be misleading. The 2010 budget of science, recently presented to Parliament by the Spanish science and Innovation Ministry , has now spread anxiety and uncertainty among the Spanish scientific community. in an open letter published in the newspaper national El Pa & iacutes , 51 biomedical researchers said their "enormous perplexity and confusion" to what some perceive as a violation of the commitment made by the Government to promote science and economy based on knowledge.
Biotech execs and patent lawyers welcome a decision by the new head of US Patent and Trademark , David Kappos. Under the pressure of a complaint filed by lawyers unhappy with proposed rules, Kappos recently abandoned procedural amendments proposed during the Bush administration that are designed to streamline operations and reduce the backlog of patent applications outstanding. For example, the "rules of continuation" provided would have limited the number of times that an application could be resubmitted for review without justification Other changes would have limited the number of applications per application Opponents -.. Including significantly GlaxoSmithKline - .. prosecuted in court to block the changes
for more on these stories and the latest news and policy analysis in science, visit science Insider
0 Komentar